AstraZeneca coronavirus vaccine produces immune response among older adults

Published



The AstraZeneca-University of Oxford COVID-19 vaccine has created immune responses in young and old adults, a promising sign that the shot could provide protection from the coronavirus.

The shot, now in late-stage human trials, also triggered lower adverse responses among the elderly, the sector of the population most vulnerable to serious illness. The company said in an announcement Monday that is likely to boost hopes that a COVID-19 vaccine is right around the corner.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.